Thank you everyone: but my post was from December 11, 2014, as a question for that day.
Did you not write this on December 22, 2014? How timely: for Dec. 23, 2014. Look at it!
The Dow is over 18,000 points. Up over 100 points today on December 23, 2014. and biotech is struggling. This biotech "bump in the road" could be more than such. We could have the next "David" to overwhelm these Goliaths, with the massive ones being focused upon. No matter how great one is, he/they/it, are not indispensable and not immune to inauspicious circumstances. This "dip" has nothing to do with the end of the year window dressing. This is what should be in the mutual funds prospectus for the end of the year, but this is working in reverse. Why would they churn now and take a tax hit so close to the conclusion of this year.
There are other underlying aspects to biotech and this is just a harbinger of the future of the stock and biotech markets. Even though Regn has seemingly a sexy pipeline, the real-deal numbers could render them impotent in the future.
Trevor: The aspect of window dressing is that the fund managers want to place certain outperforming stocks into their prospectus in order to show that they possess them. Buy selling now they will get hit will tax ramifications in the near term. So this is not the reason. There are other underlying aspects. Many of the other biotechs are dropping also. These things were overly bloated and overpriced many months prior and are now losing their cache/vogue/appeal.
Without any disrespect, for I do like the lady a great deal. She has become the new "punch bowl." She is dovish as we all know and will be patient with the interest rates - as we all knew from as of early this year in 2014. Although the QE is over, she can still move the markets and parse the language appropriate to create more steam for the markets. The ironic aspect is crude oil is down again today as it was one day the previous week when the Dow shot up over 400 points, so the general stock market is no longer moving in correlation to oil, but by every breath of language nuance emanating forth from her.
Chemistry Soul: What is Ms. Warren going to tell the Mass. shareholders of Dendreon? To take them to court? Probably so, eh? Then will the class action lawyers parade and ride in to do what? The same thing that they are noted for - a class action lawsuit. To whom does a class action lawsuit benefit? Think about this. The only ones who will come away with something salvageable are the bond holders.
And don't pray to hard for this companies turn around and reorganizing. First you should pray for your shares which you possess as of the present, that you may benefit from this - BEFORE your shares become worthless.
Rebecca: Go quickly to salvage everything you possibly can.
Dwight: Stop mentioning John Johnson, for he is no longer the ceo at Dendreon.
Dwight: I know this is in the tank, but please stop mentioning John Johnson, for he is no longer there. This makes you sound incredulous.
There is one thing that anyone shouldn't listen to, is:
Their hearts and their hopes. These are just reserved for those with the wherewithal to steer these.
Dwight223: You are still blaming Johnson. He is not the "zero equity" ceo for he is no longer the ceo of Dendreon for many weeks. Did you not know this?
Gunslinger 4812: How do you mean, my friend? As in the spirit of your comment, you are indicating this is obvious and what we learn in trading 101. Is this not the first thing any trading mentor, teacher, author or guru would impart to us? So, then, why do you not APPLY THE SAME BASIC SIMPLE THINGS?
Or are you still hoping for a 3 Billion buy out. "3B takes it." How long are you going to keep "bumping" the DNDNQ cheerleaders and even adding your own phony sophisticated diatripe to a situation which is devoid of hope?
Who is the rocket scientist now?
Give it up! Has anybody learned a lesson in all of this? No matter what the stock is, or what it does, or how glamorous or sexy the company is for the present, or if you see a cheap "value" stock, remember - it can go lower. How low? See for yourself in this case of Dendreon Q - low enough. Do the math: What is lower than one? Zero. What is lower than 08 cents? And so on and so forth.
Another lesson: Dispense with the positive thinking in the market place, or many places for that matter.
It's the market which does the thinking, and it behooves one to learn how to react.
Thank you. This is a good thought. Since LLY rose on an upgrade, this would be the appropriate time to sell in order for them to do this.
Why did LLY slide 3 plus points from its open upon receiving an upgrade this morning and also in this good market?
Devilsrain 729: You are making my point: Since there is no benefit to their buying Denedreon, as my above article had indicated, nothing will be accomplished with them in mind. No kidding.